Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Anasetti

Showing results (91-100 of 222) with videos related to

Pageof 23
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 1, 2001
Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangementsJ Pei, Y Akatsuka, C Anasetti, et al.
Bone Marrow Transplantation|December 20, 2016
Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donorsL E Perez, H Fernandez, E Ayala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cellsP A Carpenter, S Pavlovic, J Y Tso, et al.
Transplantation|January 15, 1996
Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experienceJ L Wagner, H J Deeg, K Seidel, et al.
Bone Marrow Transplantation|July 21, 2015
Donor-derived constitutional chromosomal abnormalities after allogeneic hematopoietic cell transplantation: a single-center experience and a review of the literatureT Nishihori, J El-Asmar, B Shah, et al.
Bone Marrow Transplantation|September 22, 2009
Mycophenolate mofetil for the management of steroid-refractory acute graft vs host diseaseJ Pidala, J Kim, J Perkins, et al.
Bone Marrow Transplantation|July 1, 1990
Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survivalJ A Hansen, C Anasetti, P G Beatty, et al.
Bone Marrow Transplantation|May 8, 2012
Apheresis and transplant of hematopoietic progenitor cells (HPC) from allogeneic donors of age above 60 yearsW E Janssen, D Rahn, M Hackett, et al.
The Journal of Experimental Medicine|January 1, 1993
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1P Tan, C Anasetti, J A Hansen, et al.
Bone Marrow Transplantation|August 17, 2010
Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicityJ Pidala, J Kim, C Anasetti, et al.
Pageof 23

Showing results (91-100 of 222) with videos related to

Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 1, 2001
Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangementsJ Pei, Y Akatsuka, C Anasetti, et al.
Bone Marrow Transplantation|December 20, 2016
Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donorsL E Perez, H Fernandez, E Ayala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cellsP A Carpenter, S Pavlovic, J Y Tso, et al.
Transplantation|January 15, 1996
Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experienceJ L Wagner, H J Deeg, K Seidel, et al.
Bone Marrow Transplantation|July 21, 2015
Donor-derived constitutional chromosomal abnormalities after allogeneic hematopoietic cell transplantation: a single-center experience and a review of the literatureT Nishihori, J El-Asmar, B Shah, et al.
Bone Marrow Transplantation|September 22, 2009
Mycophenolate mofetil for the management of steroid-refractory acute graft vs host diseaseJ Pidala, J Kim, J Perkins, et al.
Bone Marrow Transplantation|July 1, 1990
Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survivalJ A Hansen, C Anasetti, P G Beatty, et al.
Bone Marrow Transplantation|May 8, 2012
Apheresis and transplant of hematopoietic progenitor cells (HPC) from allogeneic donors of age above 60 yearsW E Janssen, D Rahn, M Hackett, et al.
The Journal of Experimental Medicine|January 1, 1993
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1P Tan, C Anasetti, J A Hansen, et al.
Bone Marrow Transplantation|August 17, 2010
Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicityJ Pidala, J Kim, C Anasetti, et al.
Pageof 23